Aurobindo Pharma Ltd

NSE: AUROPHARMA BSE: 524804

₹1312.50

(2.07%)

Thu, 19 Mar 2026, 10:58 pm

MTF 5xInvest in Aurobindo Pharma Ltd with 5x Leverage Buy with MTF

Market Cap746.82B

PE Ratio21.86

Dividend0.33

Health Technology

Pharmaceuticals: Other

24.5K

Aurobindo Pharma Return on Equity (ROE) History

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Price to earnings ratio	54.53	22.44	8.25	23.95	10.80	10.93	0	14.46	12.70	22.60	21.49	17.17	13.47	19.48	8.51	9.68	14.80	15.75	20.12	19.39
Price to book ratio	4.46	4.09	1.39	0.82	2.92	2.33	1.48	1.63	3.97	6.91	5.98	4.22	2.80	3.32	1.44	2.36	1.59	1.13	2.14	2.06
Price to sales ratio	2.42	2.13	0.81	0.40	1.72	1.45	0.76	0.74	1.86	2.96	3.22	2.69	2.01	2.39	1.06	2.10	1.67	1.23	2.22	2.15
Price to cash flow ratio	0	0	13.90	16.15	16.15	20.81	13.51	25.82	26.78	30.21	32.33	12.21	17.11	30.77	5.66	15.65	7.80	12.53	25.90	17.55
Enterprise value	49.79B	60.12B	35.42B	34.45B	81.56B	79.06B	64.07B	74.25B	185.12B	395.92B	477.73B	423.55B	361.61B	510.66B	272.98B	513.56B	379.05B	294.15B	641.62B	676.16B
Enterprise value to EBITDA ratio	31.86	21.18	11.15	6.34	10.59	8.54	11.92	8.89	8.92	15.77	16.06	13.11	10.10	13.82	5.61	9.47	8.51	7.70	11.23	10.49
Debt to equity ratio	1.69	2.35	1.65	1.89	1.18	0.74	1.29	1.29	1.01	0.86	0.69	0.36	0.41	0.50	0.35	0.24	0.13	0.20	0.22	0.25
Return on equity %	9.34	23.63	23.73	4.34	36.56	26.85	-5.16	11.88	36.91	35.39	32.55	27.63	23.02	18.50	18.53	27.54	11.39	7.50	11.20	11.16

Aurobindo Pharma Ltd Return on Equity

The Aurobindo Pharma Ltd Return on Equity is a key financial metric used by investors to evaluate Aurobindo Pharma Ltd's valuation, profitability, and overall financial performance. Tracking the Aurobindo Pharma Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Aurobindo Pharma Ltd (NSE: AUROPHARMA, BSE: 524804) is currently trading at ₹1312.50, with a market capitalization of ₹746.82B. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Aurobindo Pharma Ltd Return on Equity is essential for fundamental analysis.

Aurobindo Pharma Ltd Return on Equity Current Value

The current Aurobindo Pharma Ltd Return on Equity stands at 11.16.

The Aurobindo Pharma Ltd Return on Equity has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Aurobindo Pharma Ltd Return on Equity Historical Trend

The Aurobindo Pharma Ltd Return on Equity has shown the following historical trend:

2024: 11.16
2023: 11.20
2022: 7.50
2021: 11.39
2020: 27.54

The decline in Aurobindo Pharma Ltd Return on Equity indicates improving financial efficiency or better earnings growth.

What Aurobindo Pharma Ltd Return on Equity Indicates for Investors

The Aurobindo Pharma Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.

ROE indicates how efficiently the company generates returns for shareholders.

Aurobindo Pharma Ltd Return on Equity Analysis Summary

The Aurobindo Pharma Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Aurobindo Pharma Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Aurobindo Pharma Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800